Latest Headlines

Obama Names Experts to Precision Medicine Initiative

March 29, 2015

Contributed by Chempetitive Group

Much like breaking the sound barrier in 1947, the mapping of the Human Genome in 2003 was only the beginning. President Obama has called for an initiative to advance precision medicine in his latest State of the Union address.

more …

Antibody Drug Conjugates: A 3-part Series

January 2, 2015

By Juliet Preston

Antibody drug conjugates, or ADCs, are part of a promising shift in the world of cancer therapeutics — a shift that’s breaking oncology’s historic dependence on non-specific chemotherapies. This class of drugs shows promise for attacking other diseases as well, including autoimmune and degenerative diseases. But drug developers face some serious challenges, from efficacy to manufacturing.

more …

4 Reasons Every Life Science Pro Needs to Network

December 9, 2014

By Life Science Network

Whether you’re experimenting in the lab or working the tradeshow circuit for a life science company, making new connections is a powerful way to expand your career. But boosting your career is just the start. When done right, networking can result in novel research collaborations, valuable idea exchanges and lasting friendships. Here are four of the most important reasons that networking is so crucial to scientific career success.

Tags: networking more …

Top 10 Biotech IPOs of 2014: West Coast Dominates

November 20, 2014

By Life Science Network

Ultragenyx, the Novato, Calif.-based maker of treatments for rare and ultra-rare diseases, is the most successful biotech IPO of the year — raising nearly $122 million in the offering of more than 5.8 million shares. Following closely behind is ZS Pharma, a biopharmaceutical company developing and commercializing highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. Discover who else made the list, compiled by Fierce Biotech.

Tags: biotech, stocks more …

Expanding the Reach of ADC Therapies

November 7, 2014

By Juliet Preston

In 15 years, will antibody drug conjugates (ADCs) be a niche class of oncology drugs? Or will they be more widespread, used routinely in treating cancers, autoimmune diseases and even viral infections?

Tags: Antibody Drug Conjugates, conferences, drug development more …

ADC Roadblocks: Overcoming Obstacles to Innovation

November 5, 2014

By Juliet Preston

To help illustrate one of the key development challenges that drug companies face in creating new antibody drug conjugates (ADCs), consider the brief story of Myolatarg, a drug that treated patients with acute myeloid leukemia.

more …

ADCs in Focus: The Future of Cancer Therapies

October 29, 2014

By Juliet Preston on Assignment at World ADC Summit

Antibody drug conjugates, or ADCs, are part of a promising shift in the world of cancer therapeutics — a shift that’s breaking oncology’s historic dependence on non-specific chemotherapies. But as the saying goes, “it takes a village to raise a child.” And it will require a whole industry to raise these novel drug complexes into mainstream use. In pursuit of this collaboration, ADC companies and experts came together in San Diego this week for the World ADC Summit.

Tags: Antibody Drug Conjugates, conferences more …

2014 AACC Roundup: Big Data, Fertility and Faster Tests

August 11, 2014

Posted by Ken Li on Assignment at AACC 2014

The 2014 American Association for Clinical Chemistry’s (AACC) annual meeting in Chicago was packed with new information for clinicians and physicians alike. Stretched out over five days at the end of July, the sessions ranged from in-depth short courses offered by experts in the field to fascinating lectures on the future of healthcare. Here's a look at some highlights from the meeting.

more …

Discussing the Future of Translational Medicine at ON Helix 2014

July 25, 2014

Posted by Dr Paul Avery on Assignment at ON Helix 2014

The ON Helix 2014 conference, hosted by One Nucleus, brought together a distinguished list of individuals to discuss the opportunities and challenges surrounding translational research here in the UK. The conference provided us with a plethora of novel data to sink our teeth into as well as a good amount of lively discussion to top it off. From labs to boardrooms, ON Helix had something for everyone. Here are some of our highlights.

more …

Of Robots and Men: Insights from ELRIG Robotics & Automation 2014

July 25, 2014

Posted by Billy Hinchen on Assignment at ELRIG 2014

There was no shortage of ‘oohs’ and ‘ahhs’ in Northampton at ELRIG’s recent Robotics and Automation 2014 Conference (1st July), hosted by Festo. From an impressive selection of companies in the exhibition room to fascinating talks on the evolution of high throughput screening, computer active learning and the future of computer user interfaces (UIs), people were kept on the edges of their seats; hidden beneath a few of which were even tokens for a fluidic-muscle driven F1 racing simulator race contest! Oooh! Read on for a few of our favourite highlights from the event.

more …